Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
93.32B | 92.12B | 88.65B | 94.23B | 113.53B | Gross Profit |
43.94B | 42.16B | 40.36B | 42.72B | 51.77B | EBIT |
1.07B | -2.23B | -4.39B | -4.47B | -1.23B | EBITDA |
2.33B | -1.79B | -1.95B | -4.40B | -865.00M | Net Income Common Stockholders |
1.85B | -2.60B | -3.98B | -5.00B | -1.64B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
26.60B | 25.90B | 32.03B | 36.53B | 40.41B | Total Assets |
84.76B | 87.21B | 90.68B | 99.61B | 109.37B | Total Debt |
1.05B | 1.17B | 1.59B | 3.32B | 2.46B | Net Debt |
-25.55B | -24.72B | -30.44B | -33.21B | -37.95B | Total Liabilities |
32.91B | 35.86B | 35.22B | 37.14B | 39.46B | Stockholders Equity |
50.80B | 49.84B | 53.53B | 60.05B | 66.76B |
Cash Flow | Free Cash Flow | |||
2.10B | -4.29B | -4.48B | -3.35B | 354.00M | Operating Cash Flow |
2.99B | -2.98B | -3.60B | -1.72B | 1.77B | Investing Cash Flow |
-731.00M | -2.38B | 2.58B | -812.00M | -984.00M | Financing Cash Flow |
-1.29B | -1.38B | -3.47B | -1.35B | -4.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥38.43B | 14.30 | 2.86% | -1.59% | 57.60% | ||
74 Outperform | ¥567.69B | 21.22 | 10.45% | 1.10% | 17.94% | 18.31% | |
74 Outperform | ¥119.06B | 14.29 | 5.29% | 4.38% | 10.39% | ||
73 Outperform | ¥150.36B | 47.39 | 1.70% | 10.64% | 18.07% | ||
72 Outperform | ¥142.71B | 15.88 | 11.70% | 2.56% | 3.87% | -50.88% | |
68 Neutral | $334.99B | 8.71 | 8.38% | 2.10% | 6.94% | 26.04% | |
61 Neutral | $6.64B | 11.67 | 3.04% | 3.98% | 2.60% | -21.24% |